Published in Medical Letter on the CDC and FDA, December 1st, 2002
The study provided evidence used by the U.S. Food and Drug Administration (FDA) to approve RF ablation for treatment of pain in cancer patients with two or three painful bone metastatic sites. The announcement of FDA approval was made October 21, 2002.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA